The Ataxie Charlevoix-Saguenay Foundation is very pleased to announce that Dr. Marc Rivière has joined its board of directors. An executive with extensive experience creating and managing clinical programs, Dr. Rivière’s expertise encompasses all aspects of drug development.
His experience in clinical trials and his knowledge of the pharmaceutical industry could make a significant contribution to the advancement of work on ARSACS. Dr. Rivière is a General Partner and Chief Medical Officer at TVM Life Science Management.
